Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 17.65 USD -0.51% Market Closed
Market Cap: 6.2B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note

Bausch + Lomb Corp
Investor Relations

Founded in 1853, Bausch + Lomb Corp. began as a small optical goods store in Rochester, New York, eventually blossoming into a multinational eye health business. Over its long history, the company has established itself as a cornerstone in the realm of vision care, leveraging its deep expertise to innovate and expand its product offerings. Today, Bausch + Lomb operates through three primary business segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. In the Vision Care segment, it provides contact lenses, lens care products, and other related items, making it a trusted choice for consumers around the globe. The Ophthalmic Pharmaceuticals division addresses a broad spectrum of eye health needs, producing prescription and over-the-counter pharmaceuticals that target various eye conditions. Meanwhile, the Surgical segment offers a suite of ophthalmic surgical devices, designed for procedures ranging from cataract extraction to vitreoretinal surgery.

Bausch + Lomb generates revenue through a mix of consumer products and medical equipment. Their extensive contact lens product line caters to diverse needs – from daily disposables to specialized lenses for specific eye conditions, thereby capturing a significant portion of the eye care market. The company's pharmaceuticals and surgical tools not only complement its vision care products but also tap into the lucrative medical market, providing solutions for both medical professionals and their patients. By maintaining a robust portfolio that spans consumer goods and professional-grade equipment, Bausch + Lomb effectively positions itself as both a retail and medical partner, ensuring steady revenue streams from a global customer base. With a blend of research-driven innovation and strategic market positioning, Bausch + Lomb continues to cement its legacy as a leader in eye health.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Brenton L. Saunders J.D.
CEO & Chairman
No Bio Available
Mr. Osama A. Eldessouky
Executive VP & CFO
No Bio Available
Mr. A. Robert D. Bailey
Executive VP & Chief Legal Officer
No Bio Available
Dr. Yehia Hashad M.D.
Executive VP of Research & Development and Chief Medical officer
No Bio Available
Mr. Andrew Stewart
President of Global Pharmaceuticals & International Consumer
No Bio Available
Mr. Alan Waterhouse CPFA, MBA
Executive VP and Chief Supply Chain & Operations Officer
No Bio Available
Mr. Frederick J. Munsch
Senior VP, Controller & Chief Accounting Officer
No Bio Available
Mr. Jonathon L. Kellerman
Chief Compliance Officer
No Bio Available
T.J. Crawford
Chief Communications Officer
No Bio Available
Dr. Manisha A. Narasimhan Ph.D.
Chief Corporate Development & Digital Officer
No Bio Available

Contacts

Address
ONTARIO
Vaughan
520 Applewood Crescent
Contacts
+19082552864
www.bausch.com